Endoplasmic reticulum protein 29 (ERp29)

Endoplasmic reticulum protein 29 (ERp29) is a 29 kDa chaperone protein residing in the lumen of the endoplasmic reticulum, encoded by the ERP29 gene. Despite structural similarities to the protein disulfide isomerase family, ERp29 lacks the classical thioredoxin catalytic motif and is therefore redox-inactive, functioning instead as a non-classical molecular chaperone. ERp29 plays a critical role in the folding, processing, and secretion of a wide range of transmembrane and secretory proteins by escorting clients from the ER toward the Golgi apparatus. It is essential for the proper secretion of proteins such as thyroglobulin, trafficking of CFTR, ENaC, connexin 43, and also stabilizes immature collagen-I. ERp29 participates in ER stress responses and unfolded protein response pathways and directly interacts with components regulating these processes. In pathology, ERp29 has been implicated in oncogenesis (modulation of tumor suppressor and oncogene expression, radioresistance), neurodegenerative diseases, viral entry (notably polyomavirus), and diabetes via proinsulin processing. Its activity is tightly regulated by dimerization, essential for both its protein unfolding and escort functions. Although no approved drugs directly target ERp29, its roles in disease highlight potential interest for future therapy and biomarker research[1][2][3][4][5][7].

Other names

ERP29Endoplasmic reticulum protein 29Endoplasmic reticulum resident protein 29C12orf8ERp29PDI-DBPDIA9HEL-S-107Epididymis secretory protein Li 107

Not applicable for approved drugs; in experimental or hypothetical settings: - Modulating ERp29 expression or chaperone activity may theoretically affect folding/secretion of disease-related proteins (e.g., CFTR in cystic fibrosis) - Influencing ERp29 could alter ER stress and apoptosis pathways in cancer - Targeting viral interactions may prevent infection